Get started
Author

Rosalba Poggi

Practical Management of Bevacizumab-Related Toxicities in Glioblastoma
2015 · Alba A. Brandes, Marco Bartolotti, et al. · The Oncologist · 96
Relapsed Glioblastoma: Treatment Strategies for Initial and Subsequent Recurrences
2016 · Alicia Tosoni, Enrico Franceschi, et al. · Current Treatment Options in Oncology · 63
Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients?
2016 · E. Franceschi, M. Bartolotti, et al. · Journal of Neuro-Oncology · 50
The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power
2018 · Enrico Franceschi, Alicia Tosoni, et al. · World Neurosurgery · 49
PDF
Patient Outcomes Following Second Surgery for Recurrent Glioblastoma
2016 · Alba A Brandes, Marco Bartolotti, et al. · Future Oncology · 36
A Randomized Controlled Trial of Tong Len Meditation Practice in Cancer Patients: Evaluation of a Distant Psychological Healing Effect
2015 · Gioacchino Pagliaro, Paolo Pandolfi, et al. · EXPLORE · 16
Type 1 narcolepsy in anti-Hu antibodies mediated encephalitis: a case report
2018 · Maria Vitiello, Elena Antelmi, et al. · Sleep Medicine · 14
Post progression survival in glioblastoma: where are we?
2014 · Enrico Franceschi, Mario Ermani, et al. · Journal of Neuro-Oncology · 13
Resistance to Antiangiogenic Therapies
2014 · Marco Bartolotti, Enrico Franceschi, et al. · Future Oncology · 10
Vinorelbine monochemotherapy in non-small-cell lung cancer: Experience in patients with low performance status
1995 · A Masotti, G Zannini, et al. · Lung Cancer · 9
The role of systemic and targeted therapies in brain metastases
2013 · Enrico Franceschi, Marco Bartolotti, et al. · Expert Review of Anticancer Therapy · 7
Cardiac metastasis of melanoma
2005 · Rosalba Poggi, Maria Abbondanza Pantaleo, et al. · Melanoma Research · 6
Abstracts
2012 · P. Roth, M. Silginer, et al. · Neuro-Oncology · 5
PDF
Can OS-6 replace PFS-6 as a primary endpoint in phase II studies on glioblastoma patients given antiangiogenetic drugs?
2010 · E. Franceschi, A. A. Brandes, et al. · Journal of Clinical Oncology · 4
Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabine
2004 · G. Brandi, M. A. Pantaleo, et al. · International Journal of Colorectal Disease · 4
Anaplastic gliomas at first recurrence: Outcome analysis.
2012 · Enrico Franceschi, Marco Bartolotti, et al. · Journal of Clinical Oncology · 3
Prognostic factors in newly diagnosed glioblastoma: Have we missed gender?
2011 · E. Franceschi, A. Tosoni, et al. · Journal of Clinical Oncology · 3
Systemic adjuvant chemotherapy after resection of colorectal cancer metastases
2004 · Giovanni Brandi, Enrico Derenzini, et al. · Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) · 2
Clinical risk or molecular risk: What matters in low grade gliomas? A study from the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
2016 · E. Franceschi, D. De Biase, et al. · Annals of Oncology
PDF
The role of clinical risk in Low Grade Glioma patients in the era of genomic medicine: a GICNO study
2016 · E. Franceschi, D. De Biase, et al. · Annals of Oncology
PDF
Can average-risk medulloblastoma adult patients be treated with radiotherapy and plus chemotherapy?
2014 · Enrico Franceschi, Alicia Tosoni, et al. · Journal of Clinical Oncology
Re-Surgery for Recurrent Glioblastoma: Outcome Analisys and Correltion with Mgmt Status
2012 · A. Brandes, E. Franceschi, et al. · Annals of Oncology
PDF
Can Time from Last Chemotherapy to Recurrence be a Predictor of Chemosensitivity in Rcurrent Globlastoma?
2012 · E. Franceschi, R. Agati, et al. · Annals of Oncology
PDF
Natural history of glioblastoma in the modern era: Longitudinal results from a large prospective Italian register.
2012 · Alba Ariela Brandes, Enrico Franceschi, et al. · Journal of Clinical Oncology
8722 O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation status is a prognostic factor in anaplastic astrocytomas
2009 · A. Tosoni, E. Franceschi, et al. · European Journal of Cancer Supplements
Works count: 28
Citation count: 390
H-index: 9
I10-index: 9
Year
Topic
Type